Location History:
- Haverhill, MS (US) (2019)
- Haverhill, MA (US) (2020 - 2024)
Company Filing History:
Years Active: 2019-2024
Title: Beth McCormick: Innovator in Therapeutic Methods
Introduction
Beth McCormick is a prominent inventor based in Haverhill, MA (US). She has made significant contributions to the field of therapeutic methods, particularly in treating inflammation and cancer. With a total of three patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
One of her latest patents focuses on methods and compositions for treating inflammation. This invention discloses methods for targeting the pro-inflammatory MRP2/HXA3 pathway and the anti-inflammatory P-gp/endocannabinoid pathway. The patent outlines a therapeutic approach that involves administering compounds that inhibit the activity of multidrug resistance protein 2 (MRP2) and hepoxilin A3 (HXA3) synthase, as well as compounds that enhance the activity of multidrug resistance protein 1 (MRP1). This innovative method aims to reduce the migration of neutrophils into target tissues, thereby alleviating inflammation.
Another significant patent by McCormick involves compositions and methods for treating diseases using the T3SS effector protein (SipA). This invention provides a way to reduce symptoms associated with diseases that overexpress P-gp and/or p53. The compositions are particularly useful in addressing cancer symptoms and multidrug resistance. The method includes administering a composition comprising purified SipA, which can be conjugated to nanoparticles for enhanced effectiveness.
Career Highlights
Beth McCormick has had a distinguished career, working at notable institutions such as the University of Massachusetts and the University of Bath. Her research has focused on developing innovative therapeutic methods that address critical health challenges.
Collaborations
Throughout her career, McCormick has collaborated with esteemed colleagues, including Regino Mercado-Lubo and Randall Mrsny. These partnerships have contributed to her success in advancing therapeutic innovations.
Conclusion
Beth McCormick is a trailblazer in the field of therapeutic methods, with her patents reflecting her commitment to improving health outcomes. Her work continues to inspire advancements in medical treatments.